Home / Resources and Insights / Strategies for Defending Regulatory Starting Materials Desig...
Strategies for Defending Regulatory Starting Materials Designation
Less than 1 min read time
Strategies for defending regulatory starting materials designation from development through commercial launch. This executive summary covers best practices for establishing and maintaining phase-appropriate RSM designation in pharmaceutical manufacturing.
n
Form not configured. Please contact the administrator.
Related Reading
Brochure & Flyer
Streamline the import and export of drug substance and drug product between China and the US
Brochure & Flyer
Picking the Right CDMO Partner for Integrated and Accelerated Peptide Therapeutic Development
Brochure & Flyer